Trident Lifeline Share Price
Small Cap | Pharmaceuticals and health care | BSE: 543616
₹249.50 
0.00 (0.00 %)
Last Updated: 13 Mar 2025 12:00 AM
BEARISH
Overview
Open (₹) 263.00
High (₹) 263.50
Low (₹) 249.50
Prev. Close (₹) 249.50
Volume 1,800
VWAP (₹) 225.00
ROCE (%) 13.91
Industry P/E 43.95
TTM P/E 28.13
P/B Ratio 5.42
Market Cap (₹) Cr.286.91
Dividend Yield (%)--
EPS (₹) 5.52
ROE11.98%
Sales Growth (%) 40.82
Profit Growth (%)-1.26
Day Range
263.50263.50
52 Week Range
136.00339.00
Historical Returns
Returns (6M)
-19.52 %
Returns (1Y)
54.97 %
Returns (3Y)
130.7 %
Returns (5Y)
130.7 %
Returns (6M)
-19.52 %
Returns (1Y)
54.97 %
Returns (3Y)
130.7 %
Returns (5Y)
130.7 %
SWOT Analysis
- Company with Low Debt
- Book value per share improving over the last 2 years
- Increasing Annual Revenue for Past 2 Years
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
BEARISHRSI 46.36
MFI 30.16
ATR 16.86
Commodity Channel Index -166.43
ROC125 -24.95
ROC21 -13.46
Williams %R -100.00
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 225.00 | 225.00 | 225.00 | 225.00 | 225.00 | 225.00 | 225.00 |
| Week Ago | 243.34 | 246.67 | 248.34 | 241.67 | 238.34 | 236.67 | 233.34 |
| Month Ago | 268.20 | 271.40 | 273.00 | 266.60 | 263.40 | 261.80 | 258.60 |
EMA & SMA
249.50
Current Price
Bullish Moving Averages
8
Bearish Moving Averages
12
5 Day 244.56
9 Day 251.28
10 Day 248.13
12 Day 247.87
14 Day 250.56
20 Day 258.50
26 Day 260.58
50 Day 270.73
100 Day 290.60
200 Day 254.99
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| RINKAL MAYURBHAI GAJERA | bulk | Sell | 16 May, 2024 | ₹178.75 | 63,000 | BSE |
| PRSSB SERVICES LIMITED | bulk | Sell | 19 Mar, 2024 | ₹157.55 | 80,400 | BSE |
| SANDHYA SINGH GAHLOUT | bulk | Buy | 19 Mar, 2024 | ₹157.55 | 80,400 | BSE |
| SANDHYA SINGH GAHLOUT | bulk | Sell | 18 Mar, 2024 | ₹157.00 | 80,400 | BSE |
| PRSSB SERVICES LIMITED | bulk | Buy | 18 Mar, 2024 | ₹157.00 | 80,400 | BSE |
| MAYURKUMAR MANSUKHBHAI GAJERA | bulk | Sell | 06 Mar, 2024 | ₹180.00 | 57,600 | BSE |
| SANDHYA SINGH GAHLOUT | bulk | Buy | 12 Jan, 2024 | ₹183.62 | 68,400 | BSE |
| SAMBHAVNATH INVESTMENTS AND FINANCES PRIVATE LIMITED | bulk | Sell | 10 Aug, 2023 | ₹208.35 | 64,800 | BSE |
| SAMBHAVNATH INVESTMENTS AND FINANCES PRIVATE LIMITED | bulk | Sell | 29 Mar, 2023 | ₹142.51 | 70,800 | BSE |
| KOMALAY INVESTRADE PRIVATE LIMITED | bulk | Sell | 29 Mar, 2023 | ₹146.10 | 2,24,400 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 05 Mar, 2025 | ASHISH ANANDSINGH BAFNA | Acquisition | ₹222.00 | 600 | BSE |
| 05 Mar, 2025 | HARDIK DESAI FAMILY TRUST | Acquisition | ₹251.47 | 6,000 | BSE |
| 27 Sept, 2024 | TRIDENT TEXOFAB LIMITED | Disposal | ₹3,066.07 | 35,400 | BSE |
| 27 Sept, 2024 | TRIDENT TEXOFAB LIMITED | Disposal | ₹297.00 | 8,400 | BSE |
| 21 Sept, 2024 | TRIDENT TEXOFAB LIMITED | Disposal | ₹301.00 | 9,600 | BSE |
| 21 Sept, 2024 | HARDIK JIGISHKUMAR DESAI | Acquisition | ₹314.00 | 15,000 | BSE |
| 21 Sept, 2024 | RINKAL MAYURBHAI GAJERA | Disposal | ₹314.00 | 15,000 | BSE |
| 16 Sept, 2024 | TRIDENT TEXOFAB LIMITED | Disposal | ₹310.00 | 6,000 | BSE |
| 16 Sept, 2024 | HARDIK DESAI FAMILY TRUST | Acquisition | ₹316.00 | 5,400 | BSE |
| 16 Sept, 2024 | RINKAL MAYURBHAI GAJERA | Disposal | ₹305.57 | 41,400 | BSE |
Corporate Actions
No corporate actions available.
Announcements
| Date | Source | Detail |
|---|---|---|
| 12 Mar, 2025 | BSE India | Trident Lifeline Limited has provided Corporate Guarantee in favor of Yes Bank |
| 05 Mar, 2025 | BSE India | Trident Lifeline Limited is pleased to inform you about the strategic alliance with National Institutes of Pharmaceutical Education and Research- Ahmedabad (NIPER-A) |
| 05 Mar, 2025 | BSE India | Pursuant to Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations), we are enclosing herewith the disclosures received by the Company under Regulation 7(2) of PIT Regulations, from Mr. Ashish Anandsingh Bafna, Chief Financial Officer of the Company in Form C with respect to acquisition of Equity Shares of the Company |
| 05 Mar, 2025 | BSE India | In compliance with Regulation 29 of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, please find enclosed herewith disclosure received from Mr. Ashish Anandsingh Bafna, Chief Financial Officer of the company in terms of sub regulation (1) of said regulation in the format prescribed. |
| 05 Mar, 2025 | BSE India | Pursuant to Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations), we are enclosing herewith the disclosures received by the Company under Regulation 7(2) of PIT Regulations, from Mr. Hardik Jigishkumar Desai, Trustee of Hardik Desai Family Trust, Promoter Group Member of the Company in Form C with respect to purchase of Equity Shares of the Company. |
| 05 Mar, 2025 | BSE India | In compliance with Regulation 29 of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, please find enclosed herewith disclosure received from Mr. Hardik Jigishkumar Desai, Trustee of Hardik Desai Family Trust, Promoter Group Member, in terms of sub regulation (2) of said regulation in the format prescribed. |
| 25 Feb, 2025 | BSE India | Trident Lifeline Limited has provided Corporate Guarantee in favor of Yes Bank on behalf of its Subsidiary Company. |
| 14 Feb, 2025 | BSE India | Trident Lifeline Limited has provided Corporate Guarantee to Subsidiary of the Company. |
| 04 Feb, 2025 | BSE India | With reference to our intimation dated December 23, 2024 and January 22, 2025 we wish to inform to the Exchange that the said transaction as mentioned in the above intimation for proposed acquisition of 51% of the total issued and paid up share capital of TRIDENT MEDIQUIP LIMITED (CIN: U33309GJ2019PLC110421) from existing shareholders of the Company and making it a subsidiary company has been completed on February 04, 2025 at 09:32 a.m. |
| 22 Jan, 2025 | BSE India | Company has submitted integrated filing (Financial) for Quarter and nine months ended December 31, 2024. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 17 Jan, 2025 | 22 Jan, 2025 |
| Half Yearly Results | -- | 16 Oct, 2024 | 19 Oct, 2024 |
| Quarterly Results | -- | 16 Jul, 2024 | 17 Jul, 2024 |
| Audited Results | (Revised) | 23 Apr, 2024 | 27 Apr, 2024 |
| Audited Results | -- | 23 Apr, 2024 | 22 Apr, 2024 |
| Half Yearly Results | -- | 27 Oct, 2023 | 04 Nov, 2023 |
| Quarterly Results | -- | 12 Jul, 2023 | 15 Jul, 2023 |
| Audited Results | -- | 28 Apr, 2023 | 06 May, 2023 |
| Quarterly Results | -- | 10 Jan, 2023 | 16 Jan, 2023 |
Share Holding Pattern
| Owner Name | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 | Sept, 2023 |
|---|
About Trident Lifeline
Trident Lifeline is a Public Limited Listed company incorporated on 09/01/2014 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L51909GJ2014PLC078227 and registration number is 078227. Currently company belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 44.65 Cr. and Equity Capital is Rs. 11.50 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
2014
Managing Director
Mr. Shravan Harikrishna Patel
NSE Symbol
--
Trident Lifeline Management
| Name | Designation |
|---|---|
| Mr. Hardik Jigishkumar Desai | Chairman & Executive Director |
| Mrs. Rupaben Chetan Jariwala | WholeTime Director & CFO |
| Mr. Shravan Harikrishna Patel | Managing Director |
| Mrs. Maniya Hardik Desai | Non Executive Director |
| Mr. Mishal Shailesh Patel | Independent Director |
| Mrs. Falguni Bhavesh Jariwala | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,03,916.05 | ₹1,683.45  ₹1,676.85(0.39%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,49,205.29 | ₹5,620.45  ₹5,667.15(-0.82%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,18,065.23 | ₹1,461.90 ₹1,454.30(0.52%) | ₹1,317.600 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,03,430.62 | ₹3,056.05 ₹3,096.50(-1.31%) | ₹2,488.000 - ₹3,589.950 |
| Dr. Reddy's Laboratories | ₹92,453.48 | ₹1,107.95 ₹1,105.15(0.25%) | ₹1,093.000 - ₹1,420.200 |
FAQs on Trident Lifeline
What is the share price of Trident Lifeline?
The share price of Trident Lifeline on 13 Mar, 2025 is ₹ 249.50.
What is 52W high and 52W low share price of Trident Lifeline?
The highest and lowest 52W share prices of Trident Lifeline are ₹ 339.000 and ₹ 136.000
What is the market cap of Trident Lifeline?
The market capitalization of Trident Lifeline as of 13 Mar, 2025 is ₹ 286.91 Crores
What is the P/E ratio of Trident Lifeline?
The current P/E ratio of Trident Lifeline as of 13 Mar, 2025 is 43.95
What is the PB ratio of Trident Lifeline?
The PB ratio of Trident Lifeline as of 13 Mar, 2025 is 5.42
Top Gainers
₹41.02
₹34.29 (0.20%)
₹8.84
₹7.37 (0.20%)
₹6.97
₹5.81 (0.20%)
₹194.70
₹162.25 (0.20%)
Top Losers
₹13.75
₹135.15 (-0.90%)
₹9.60
₹12.00 (-0.20%)
₹9.80
₹93.55 (-0.90%)
₹0.99
₹4.77 (-0.79%)
Market Indices
Sensex
₹73,828.91
₹74,029.76 (0.00%)